Evidence map›Paper›PMID 41377106›Full record

ArticleBio-protocol2025

Implementation of Fusion Primer-Driven Racket PCR Protocol for Genome Walking.

Yinwei Gu, Jinfeng Pei, Mou Li, Qingchun Tang, Haixing Li

Abstract read
In one paragraph

Article in Bio-protocol, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yinwei GuState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
Jinfeng PeiCurrent/Present address: Research and Development Center, Classy·Kiss Dairy Co., LTD, Suzhou, China.
Mou LiState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
Qingchun TangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
Haixing LiState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-walking protocols have been extensively used to clone unknown genomic sequences next to known DNAs. Existing genome-walking protocols need further improvement in methodological specificity or operation. Here, we describe a novel genome-walking protocol based on fusion primer-driven racket PCR (FPR-PCR). FPR-PCR involves four sequence-specific oligos (SSO), SSO1, SSO2, SSO3, and SSO4, which are sequentially chosen from known DNA in the direction 5'→3'. The fusion primer, mediating primary FPR-PCR, is generated by attaching SSO3 to the 5' end of SSO1. The SSO3 encourages the target DNA of primary PCR to form a racket-like structure by mediating intra-strand annealing. SSO2 and SSO4 are directly used as sequence-specific primers (SSP) in secondary FPR-PCR, which selectively amplifies this racket-like DNA. This protocol was verified by cloning several unknown genomic sequences. Compared to traditional PCRs, FPR-PCR offers the advantages of higher specificity and fewer rounds, primarily attributed to the omission of arbitrary walking primers typically required in traditional methods. Key features • This FPR-PCR protocol builds upon the method constructed by Pei et al. [1]. • The FPR-PCR protocol relies on a multi-functional fusion primer (FP) that mediates the primary amplification and the formation of racket-like DNA. • The FPR-PCR comprises only two rounds of amplification reactions.

Indexed as

Fusion primerGenome-walking PCRIntra-strand annealing of DNAPartial annealingRacket-like DNASequence-specific primer

Identifiers

PMID41377106
PMCPMC12689162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.